DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Matrix Geo Solutions Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 1 hr ago·14 Oct 2026, 5:04 am

Matrix Geo Solutions

Matrix Geo Solutions Limited (MGSL) has informed stock exchanges that it has received a mandatory compliance certificate under SEBI's Depositories and Participants Regulations. This document confirms that the company has successfully deposited its shares with the designated depository participant for the quarter ending September 30, 2026. It serves as official proof that the company's shareholding process is in line with regulatory requirements.

For investors, this news is largely procedural and confirms that the company's shareholding records are being maintained correctly. It does not indicate any financial distress or operational issues. Compliance with SEBI regulations is a standard requirement for listed entities to ensure transparency in shareholding patterns.

Investors should note that this is a routine regulatory filing. There is no immediate impact on the stock's price or the company's operations. The focus now shifts to the company's upcoming quarterly results and business performance, which will be more relevant for investment decisions.